2015
DOI: 10.1155/2015/757821
|View full text |Cite
|
Sign up to set email alerts
|

Advances in the Endoscopic Management of Obesity

Abstract: Obesity has become a worldwide epidemic with significant impact on quality of life, morbidity, and mortality rates. Over the past two decades, bariatric surgery has established itself as the most effective and durable treatment for patients with obesity and its associated comorbidities. However, despite the use of minimally invasive techniques, bariatric surgery is associated with complications in approximately 15% of patients, has a substantial cost, and is used by only 1% of patients who are eligible. Theref… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 70 publications
0
22
0
Order By: Relevance
“…Clinically relevant weight loss was reported with a fifth device (EndoBarrier, GI Dynamics, Inc., Lexington, MA, USA; Patel, Hakim, Mason, & Hakim, ); however, clinical trials were terminated in July 2015 due to concerns over bacterial infections (GI Dynamics, ). Endoscopic devices are usually less invasive and costly than traditional surgery, and can be reversed and/or repeated (Behary & Kumbhari, ). However, they are frequently performed by physicians not typically responsible for obesity management (e.g., gastroenterologists), further increasing the need for clear guidance and care pathways.…”
Section: Need For Consensus On Disease Staging Guidelines and Treatmentioning
confidence: 99%
“…Clinically relevant weight loss was reported with a fifth device (EndoBarrier, GI Dynamics, Inc., Lexington, MA, USA; Patel, Hakim, Mason, & Hakim, ); however, clinical trials were terminated in July 2015 due to concerns over bacterial infections (GI Dynamics, ). Endoscopic devices are usually less invasive and costly than traditional surgery, and can be reversed and/or repeated (Behary & Kumbhari, ). However, they are frequently performed by physicians not typically responsible for obesity management (e.g., gastroenterologists), further increasing the need for clear guidance and care pathways.…”
Section: Need For Consensus On Disease Staging Guidelines and Treatmentioning
confidence: 99%
“…Endoscopic modalities in the treatment of obesity can be categorized into the following: space-occupying devices (intragastric balloon [IGB], transpyloric shuttle), gastric restrictive methods (transoral gastroplasty, transoral endoscopic restrictive implant system), malabsorptive endoscopic procedures (duodenal-jejunal bypass liner, satiSphere), regulating gastric emptying (intragastric botulinum toxin injections, gastric electrical stimulation), and other therapies (aspiration therapy) [14][15][16]. Of these methods, the most commonly employed is IGB placement.…”
Section: Introductionmentioning
confidence: 99%
“…In bariatric surgery these risks mainly comprises malabsorption and surgical complications related to leakage from anastomoses or internal herniation of small bowel. In recent years new endoscopic techniques have emerged, thus providing less invasive options for treatment of obesity [15, 16]. …”
Section: Introductionmentioning
confidence: 99%